WeylChem Group of Companies’ Post

Synonym : Very interesting publication for a very relevant issue. But if I am not wrong it seems that the meaning of #Biofoundry adopted in this report is a little bit confusing. Instead using #Biomanufacturing facility would be more appropriate. Actually biofoundry stands for a dedicated unit for designing strains 🆚 biomanufacturing plant which is a facility for implementing these engineered strains at industrial scale for producing a broad range of bioproducts

🌍 The market that will open up to startups that manage to bring down the cost of manufacturing bioproducts 🏭 is simply immense 😳.  👉 This is precisely the objective of Catsalyze, thanks to its proprietary technology. And with enzymatic biocatalysis. The #reindustrialization of #France begins with the production in France of biosourced and cleanly produced chemical molecules. Thank you Synonym and Boston Consulting Group (BCG) SAYENS Alexis Boutilliat Incubateur Lorrain Natacha Hauser-Costa ADEME Bruno Bonnell Bpifrance France Deeptech Abdelkader GUELLIL Damien Debecker Florent Allais, FRSC France Chimie Chemtech Bioeconomy For Change Romain Foussadier Brice Gianesini NetZero Team for the Planet Anaïs Voy-Gillis Nicolas Dufourcq

Here we go - some thoughts around #biomanufacturing from Synonym and Boston Consulting Group (BCG) and the cost barriers. A few good ideas included, and a good write-up also for financial or economic driven colleagues, not only us geek #engineers. I am happy to share in my network. download for free and share your thoughts. A bit confusing to me is the use of the term "biofoundries" in the report, where they call it: (quote) "These in turn require construction and optimization of biofoundries—large-scale, standardized biomanufacturing facilities that can meet industrial-level demand— and continued improvements in strain engineering."(end quote) While I can agree to a good extent to the need of such hubs / sites, the term "biofoundry" has been coined and is recognized by most people to be a highly automated and computer aided DBTL infrastructure, capable of escalating (not always accelerating) the synthetic biology workflow towards improved strain geno- and phenotypes. Also "precision fermentation" is a term used to allow the food industry (in the advent of alternative proteins showing up again and saw traction) to differentiate from their fermentation (like prebiotics or beer) with the way the rest of the world ferments (pharma, chemistry, etc). Its a bit misleading in my opinion, and leaned towards the food sector primarily. #biotechnology #scaleup

The full agenda was released yesterday - check your inboxes or head to the website to get access. The countdown is on! #Bioeconomy #IndustrialBiomanufacturing #Biobased #WBM24 #Greenmanufacturing #Partnerships #Investment #BusinessDevelopment

10 weeks today World Bio Markets 2024 will be in full swing with hundreds (if not thousands) of pre arranged 1-2-1 commercial deal flow meetings in progress. The commercialisation (taking far too long) and growth of the sector is at the heart of the events value proposition and so if you are in industrial biomanufacturing (or want to understand how it can support your defossilization strategy) then visit www.worldbiomarkets.com to see the best way for you to be involved... all are welcome and budget is not a barrier! Bio developers & producers, investors & financiers, global consumer brands, chemical manufacturers, community enablers and suppliers... come and coalesce. ... oh and our conference agenda is released today for download and so keep an eye on your inbox. #bioeconomy #industrialbiomanufacturing #biobased #greenmanufacturing #dealflow #partnerships #investment #businessdevelopment #pipeline #connect #biomaterials #biochemicals #bioingredients #boldgoals

After months in the works, today our team is excited to announce our new report in collaboration with The Boston Consulting Group (BCG) that sheds light on the path for #biomanufacturing to reach $200 billion in speciality markets over next decade. The report offers detailed insights for transitioning the global economy to more sustainable, efficient, and cost-effective methods of production and points to next-generation biofoundries as key catalysts for the coming wave of superior products. Demand is solidifying for bioproducts, which leverage the power of engineered microorganisms and biological processes in place of traditional production methods. But for change to happen, costs must come down. Key insights from the report include: 🔎Optimized large-scale facilities can lower production costs by as much as 50% on existing strains. 🔎More and larger facilities and improved strains could reduce production costs by up to 90%, achieving or surpassing price parity with incumbent methods for most products. 🔎 The market for biomanufactured ingredients in three industries alone—specialty chemicals, food, and chemical precursors could reach $200 billion by 2040. Dive into our insights and learn more here: https://lnkd.in/eGXcf-h9 #sustainability #bioeconomy #fermentation #precisionfermentation #bioproducts #biomaterials #biomassfermentation #climate #alternativeproteins #foodtech #specialtychemicals

Our Founder and CEO, Ajikumar Parayil, was invited to speak at The White House to share the tangible strides we have made in advancing biotechnology and biomanufacturing in the U.S.  On the two-year anniversary of the launch of the National Biotechnology and Biomanufacturing Initiative (NBBI), Aji spoke alongside industry leaders and senior officials about the significant progress in domestic biomanufacturing – and how it presents an incredible opportunity to drive supply chain security and create jobs. Right here in the U.S.  On the heels of the announcement of our strategic partnership with Tate & Lyle, Aji also shared the significance of The Natural Sweetener Alliance as a defining moment for the future of biomanufacturing, industrial biotechnology, and bioalternatives. Leveraging Manus' advanced bioalternatives scale-up platform, this partnership will accelerate innovation, provide greater supply chain security, and grow the global natural sweeteners market, driving down sugar consumption worldwide and making healthier, high-quality options more accessible. Learn more about The Natural Sweetener Alliance: https://lnkd.in/ePgYJPF2 #manufacturing #biomanufacturing #supplychainsecurity #MadeByManus

Hello Everyone, From July 29 to 31, the Biocontrol & Biostimulants LATAM event will take place at the Royal Palm Hall in Campinas/SP. Organize yourself, and if possible, break from the routine and think about the future of agribusiness. Market studies indicate that in 10 to 15 years, the chemical industry aims for approximately 70% of its revenues to come from "bioinsumos" and related actions. Those who take the lead will have a significant competitive advantage. Some key points that reinforce these numbers: - Sustainability as a priority for the final consumer; - Producers open to using new technologies; - Carbon sequestration as part of the sustainability strategy; - Margins offered by specialties; - Producers becoming more technical and needing adequate support; - New players and new technologies that increase production. Event link: Biocontrol LATAM https://lnkd.in/dhjw7p-y Speakers: https://lnkd.in/dNbEzFTH Have a great week!

The Future of Surfactants Summit taking place on 22nd & 23rd May 2024 in Seville, Spain. £190 Early Bird Discount Expiring on 29th February! Book your space now! The standard delegate rate will increase to £1,995 from 1st March 2024! https://lnkd.in/gkQg8fy Key Topics Include: ·       Designing A Circular Economy Model for the Surfactants Industry ·       Updates within the European & Global Market ·       Moving Towards Oleochemical Feedstocks ·       Gaining a Better Understanding of Consumer Needs ·       Adopting More Sustainable Practices within the Industry ·       Emerging Trends & Future Directions in Surfactant Research ·       Advances of AI Technology & its Improvement in Surfactants Early Confirmed Speakers Include: Alfonso Lag Brotons, Project Scientific Officer, European Commission Kurt Koninckx, Director of Regional Business EMEA, Indorama Dorothee Arns, Director General, FECC Eric Hudson, Managing Consultant, NexantECA Nivatha Balendra, CEO & Founder, Dispersa Amir Al Ghatta, CEO & Co-Founder, Bioataraxis Jordan Petkov, Research Fellow, Director Business Development, Arxada Dr. Maria de Moragas, Marketing Manager, Home Care/I&I Europe, BASF Jiwon Sung, Senior System Manager, ISCC System Previous edition’s attendees included: Arxada * Bessler Consulting GmbH * Bio Base Europe * Bioataraxis Itd * Biolin Scientific * Cargill * Cepsa * Chemical Industries * Clariant * Croda * Desmet * Evonik * ExxonMobil * Fecc - European Association Of Chemicals Distributors * Fuchs Lubricant * Holiferm * Jiahua Chemicals * Kaneka * Kline Group * Levaco Chemicals * Libra Specialty Chemicals * Locus Performance Ingredients * Lonza * Lubrizol * McBride * Merck Group * Neste * Nexant * Oils & Fats International * Reckitt Benckiser * S&P Global * Sasol * Sc Johnson Professional * Sisterna * Univar Solutions * Untapped Innovation * VTT amongst others… #chemicals #surfactants #futureofsurfactants #cosmetics #homecare #conferences

Compelling report from Boston Consulting Group (BCG) and Synonym contributors, including Jean-Francois Bobier, Tristan Cerisy, PhD, Anne-Douce Coulin Kuhlmey, Crystal Bleecher, PE, Victoria Sassoon and Brentan Alexander, on bringing costs down in biomanufacturing. A worthy goal considering the estimate that “scaling up industrial precision fermentation can create a $200 billion market by 2040, seven times the current size, if companies build enough production capacity to lower costs.” As demand for products that use bioalternatives grows, driven by the desire to build sustainable manufacturing processes while reducing carbon emissions, the need for large-scale, biomanufacturing facilities that can meet industrial-level demand and cost-targets grows. Creating this capacity is why Manus built one of the largest piloting and large-scale manufacturing BioFacilities in the Americas. Providing the opportunity for large-scale manufacturing and optimizing strains with large-scale manufacturing in mind are both integral for efficient scaling and cost-effective biomanufacturing. Read the full report: https://lnkd.in/eGXcf-h9 Learn more about our scale-up capabilities: https://bit.ly/42Yd1iB #bioeconomy #biomanufacturing #biotechnology #syntheticbiology #MadeByManus